Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
$2.11M Sell
39,274
-96,014
-71% -$5.32M 0.03% 706
2017
Q3
$8.27M Buy
135,288
+51,045
+61% +$3.09M 0.15% 235
2017
Q2
$5.15M Buy
84,243
+32,276
+62% +$1.96M 0.11% 340
2017
Q1
$3.15M Buy
51,967
+15,335
+42% +$930K 0.07% 497
2016
Q4
$2.06M Buy
36,632
+11,248
+44% +$658K 0.06% 500
2016
Q3
$1.51M Buy
25,384
+6,743
+36% +$394K 0.06% 469
2016
Q2
$1.02M Buy
18,641
+3,569
+24% +$190K 0.06% 433
2016
Q1
$761K Sell
15,072
-40,817
-73% -$2M 0.05% 460
2015
Q4
$2.82M Buy
55,889
+41,978
+302% +$2.12M 0.22% 162
2015
Q3
$656K Sell
13,911
-85,312
-86% -$4.53M 0.1% 276
2015
Q2
$5.39M Sell
99,223
-4,241
-4% -$238K 0.21% 145
2015
Q1
$5.67M Buy
103,464
+52,751
+104% +$2.99M 0.23% 119
2014
Q4
$2.75M Buy
50,713
+41,765
+467% +$2.33M 0.14% 282
2014
Q3
$506K Buy
+8,948
New +$502K 0.04% 485

Other funds holding MRK

AHL Partners's MRK Position: Q4 2017 in Review

AHL Partners reduced its Merck (MRK) stake by 71% in Q4 2017, selling an estimated $5.32M and leaving 39,274 shares worth $2.11M. The position accounts for 0.03% of the portfolio, ranked #706.

AHL Partners first reported a position in MRK in Q3 2014 and has held it in 14 quarters since. The position peaked at $8.27M in Q3 2017. 2,008 funds tracked by Wall St. Rank hold MRK as of Q4 2017.

  • AHL Partners held 39,274 shares of Merck worth $2.11M as of Q4 2017.
  • AHL Partners sold 96,014 Merck shares in Q4 2017, an estimated $5.32M.
  • Merck made up 0.03% of AHL Partners's portfolio in Q4 2017, its #706 holding.
  • AHL Partners first reported a position in Merck in Q3 2014 and has held it in 14 quarters since.
  • AHL Partners's Merck position peaked at $8.27M in Q3 2017.
  • 2,008 funds tracked by Wall St. Rank held Merck as of Q4 2017.

Based on AHL Partners's 13F filing for Q4 2017, filed 14 Feb 2018.